Skip to main
HYFT

HYFT Market Capitalization Overview

Market Cap: $70.44M as of Oct 9, 2026

$70.44M
$9.82M (16.20%)past month
As of Oct 9, 2026, HYFT has a market capitalization of $70.44M. Over the past 30 days, its market cap has increased by 2.58%, while in the last 12 months, it has decreased by -17.12%.

Market capitalization represents the total value of ImmunoPrecise Antibodies Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

HYFT Market Cap Formula = Stock Price * Shares Outstanding

The market cap of HYFT helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

HYFT Market Cap History

DateMarket CapChange
Oct 1, 2026$62.66M+2.58%
Sep 1, 2026$61.09M-3.70%
Aug 3, 2026$63.44M-16.18%
Jul 1, 2026$75.68M-6.90%
Jun 1, 2026$81.28M+43.80%
May 1, 2026$56.53M+6.14%
Apr 1, 2026$53.26M+0.04%
Mar 2, 2026$53.23M-29.63%
Feb 2, 2026$75.64M-19.80%
Jan 2, 2026$94.32M+11.66%

HYFT End of Year Market Cap History

DateMarket CapChange
2026$70.44M-17.12%
2025$84.98M+727.77%
2024$10.27M-75.92%
2023$42.64M-67.18%
2022$129.92M+24.74%
2021$104.15M—

FAQs About ImmunoPrecise Antibodies Ltd (HYFT) Market Cap

As of Oct 9, 2026, the market capitalization of HYFT is $70.44M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, ImmunoPrecise Antibodies Ltd’s market capitalization has increased by 16.20%, changing from $60.62M to $70.44M as of Oct 9, 2026.

In the last 3 months, ImmunoPrecise Antibodies Ltd’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, ImmunoPrecise Antibodies Ltd’s market capitalization increased from $10.27M in January to $84.98M in December, reflecting a 727.77% change.

In the past five years, HYFT has had a compound annual growth rate (CAGR) of -3.99% in market capitalization. This means its market cap has shrunk at an average rate of -3.99% per year.

ImmunoPrecise Antibodies Ltd (HYFT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.